Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Completed

Conditions studied: Hemophilia

In brief

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.

Key facts

Study ID

NCT05904210

Run by

Laboratoire français de Fractionnement et de Biotechnologies

People needed

17

Starts

2023-11-07

Expected to finish

2024-05-09

Last updated by the study team

2024-06-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient received SEVENFACT® before study initiation.
• If collection of a written informed consent is required for an investigational site (see Section 5.1 General Informed Consent), patient has read, understood, and documented written informed consent/assent.

You may not qualify if…

• Not applicable

Where it is running

• Luskin Orthopaedic Institute for Children — Los Angeles, California, United States
• Valley Children's Hospital — Madera, California, United States
• Children's healthcare of Atlanta — Atlanta, Georgia, United States
• Mayo Clinic — Rochester, Minnesota, United States
• SUNY Upstate Medical University, Pediatric Hematology/Oncology — Syracuse, New York, United States
• University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States
• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
• The Gulf States Hemophilia & Thrombophilia Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.